Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis. [electronic resource]
Producer: 20100621Description: 501-8 p. digitalISSN:- 1865-3774
- Agammaglobulinemia -- drug therapy
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- B-Lymphocytes -- drug effects
- Bleomycin -- administration & dosage
- Cell Differentiation -- drug effects
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Homeostasis -- drug effects
- Humans
- Immunophenotyping
- Lymphoma, Follicular -- drug therapy
- Middle Aged
- Prednisone -- administration & dosage
- Procarbazine -- administration & dosage
- Rituximab
- Severity of Illness Index
- T-Lymphocytes -- drug effects
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.